Literature DB >> 12516771

Interferon regulatory factor 1 in mycobacterial infection.

Hiroyuki Yamada1, Satoru Mizuno, Isamu Sugawara.   

Abstract

In order to understand the role of IRF-1 in the development of murine tuberculosis in vivo, IRF-1 knockout mice were infected with Mycobacterium tuberculosis by placing them in the exposure chamber of an airborne infection apparatus. These knockout mice developed multifocal necrotic lesions in the lung, liver and spleen tissues and died of disseminated tuberculosis within 43 days of infection. Compared with the levels in wild-type mice, the pulmonary inducible NO synthase (iNOS) mRNA expression level was significantly lower, but IL-18 and IL-6 mRNA levels were higher. There was no statistically significant difference in the expression of IFN-gamma and TNF-alpha mRNA between the IRF-1 knockout and wild-type mice. IRF-1 is indirectly responsible for iNOS mRNA expression and plays an important role in the pathogenesis of murine tuberculosis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12516771     DOI: 10.1111/j.1348-0421.2002.tb02760.x

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  16 in total

1.  Crohn's disease and genetic hitchhiking at IBD5.

Authors:  Chad D Huff; David J Witherspoon; Yuhua Zhang; Chandler Gatenbee; Lee A Denson; Subra Kugathasan; Hakon Hakonarson; April Whiting; Chadwick T Davis; Wilfred Wu; Jinchuan Xing; W Scott Watkins; Michael J Bamshad; Jonathan P Bradfield; Kazima Bulayeva; Tatum S Simonson; Lynn B Jorde; Stephen L Guthery
Journal:  Mol Biol Evol       Date:  2011-08-04       Impact factor: 16.240

Review 2.  IL12Rβ1: the cytokine receptor that we used to know.

Authors:  Richard T Robinson
Journal:  Cytokine       Date:  2014-12-13       Impact factor: 3.861

3.  Disseminated and rapidly fatal tuberculosis in mice bearing a defective allele at IFN regulatory factor 8.

Authors:  Jean-François Marquis; Ronald LaCourse; Lynn Ryan; Robert J North; Philippe Gros
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

4.  Pathological and immunological profiles of rat tuberculosis.

Authors:  Isamu Sugawara; Hiroyuki Yamada; Satoru Mizuno
Journal:  Int J Exp Pathol       Date:  2004-06       Impact factor: 1.925

5.  Early secreted antigenic target of 6-kDa protein of Mycobacterium tuberculosis primes dendritic cells to stimulate Th17 and inhibit Th1 immune responses.

Authors:  Xisheng Wang; Peter F Barnes; Fangfang Huang; Ivana B Alvarez; Pierre F Neuenschwander; David R Sherman; Buka Samten
Journal:  J Immunol       Date:  2012-08-17       Impact factor: 5.422

6.  Evidence for postinitiation regulation of mRNA biogenesis in tuberculosis.

Authors:  Hugh Salamon; Yaming Qiao; Jeff C Cheng; Ken D Yamaguchi; Patricia Soteropoulos; Michael Weiden; Maria Laura Gennaro; Richard Pine
Journal:  J Immunol       Date:  2013-02-01       Impact factor: 5.422

7.  Retinoic acid therapy attenuates the severity of tuberculosis while altering lymphocyte and macrophage numbers and cytokine expression in rats infected with Mycobacterium tuberculosis.

Authors:  Hiroyuki Yamada; Satoru Mizuno; A Catharine Ross; Isamu Sugawara
Journal:  J Nutr       Date:  2007-12       Impact factor: 4.798

8.  Interferon regulatory factor-1 in flagellin-induced reprogramming: potential protective role of CXCL10 in cornea innate defense against Pseudomonas aeruginosa infection.

Authors:  Gi Sang Yoon; Chen Dong; Nan Gao; Ashok Kumar; Theodore J Standiford; Fu-Shin X Yu
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-11-15       Impact factor: 4.799

9.  Tagging single nucleotide polymorphisms in the IRF1 and IRF8 genes and tuberculosis susceptibility.

Authors:  Shiping Ding; Tao Jiang; Jianqin He; Beibei Qin; Shuangyan Lin; Lanjuan Li
Journal:  PLoS One       Date:  2012-08-06       Impact factor: 3.240

10.  Irf8-regulated genomic responses drive pathological inflammation during cerebral malaria.

Authors:  Joanne Berghout; David Langlais; Irena Radovanovic; Mifong Tam; John D MacMicking; Mary M Stevenson; Philippe Gros
Journal:  PLoS Pathog       Date:  2013-07-11       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.